fotemustine has been researched along with ethylene chlorohydrin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Breen, M; Brownsill, R; Gordon, BH; Gray, AJ; Hiley, M; Ings, RM; Marchant, N; Richards, R; Taylor, AR; Wallace, D | 1 |
Biron, P; Evene, E; Giroux, B; Gordon, B; Lucas, C; Mornex, F; Richards, R; Roux, N; Solere, P; Tranchand, B | 1 |
1 trial(s) available for fotemustine and ethylene chlorohydrin
Article | Year |
---|---|
Phase I pharmacokinetics study of high-dose fotemustine and its metabolite 2-chloroethanol in patients with high-grade gliomas.
Topics: Adult; Antineoplastic Agents; Bone Marrow Transplantation; Brain Neoplasms; Ethylene Chlorohydrin; Female; Glioma; Half-Life; Humans; Male; Metabolic Clearance Rate; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds | 1993 |
1 other study(ies) available for fotemustine and ethylene chlorohydrin
Article | Year |
---|---|
Disposition, pharmacokinetics, and metabolism of 14C-fotemustine in cancer patients.
Topics: Aged; Antineoplastic Agents; Carbon Radioisotopes; Ethylene Chlorohydrin; Feces; Female; Half-Life; Humans; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Ovarian Neoplasms; Prostatic Neoplasms; Time Factors | 1990 |